In a large case-control study on 515 hospitalized black patients with thromboembolism and Hb S and C and 555 black controls revealed that persons with SCT experienced approximately a 2-fold increased risk of venous thromboembolism (VTE) compared with persons with the wild-type genotype, Hb AA. This evidence concerns the gene GSTM1 and Thromboembolism.